carboplatin , an analog of cisplatin , was evaluated in a phase ii study involving 25 patients with advanced testicular tumor and 45 with transitional cell carcinoma ( tcc ) of the urinary tract ;
C0008838
cisplatin
C0039590
testicular tumor